Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Sign-on Letter to HHS Supporting Continuation of the ACHDNC
-
ACMG Comments to CMS Regarding CY 2020 CLFS Preliminary Payment Determinations
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network
-
Group Letter to Congress Supporting the Newborn Screening Saves Lives Reauthorization Act (NBSSLRA) of 2019
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
Group Sign-on Letter to Congress (House) Requesting FY 2019 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to Congress (Senate) Requesting FY 2019 Appropriations for Newborn Screening Programs
-
ACMG Comments to CMS Concerning CLFS Gapfill Preliminary Determinations for GS Codes 81425, 81426, and 81427
-
Group Sign-on Letter to Congress Requesting FY 2019 Appropriations for the National Institute of Child Health and Human Development (NICHD)
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations